510(k) device
SpaceOAR Vue Hydrogel
Augmenix, Inc. · Hydrogel Spacer (OVB, Class II) · First FDA decision Jul 19, 2019, newest Jul 19, 2019Cancer radiation therapyProstate cancer
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
5
Naming "SpaceOAR Vue"
MAUDE reports
1,137
Brand "SpaceOAR Vue", since 2015
PubMed studies
6
Mentioning "SpaceOAR Vue"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing SpaceOAR Vue Hydrogel
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- SpaceOAR Vue Hydrogel510(k)
K182971 · Decided Jul 19, 2019 · 266 days after receipt
Device type: Hydrogel Spacer (OVB) · Radiology & Imaging
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "SpaceOAR Vue", any status and sponsor, newest update first.
- Effectiveness of the SpaceOAR Vue System in Subjects With Prostate CancerPivotal-lookingActive, not recruiting
Boston Scientific CorporationPublic (BSX)
NCT04905069 · 500 participants · Start Dec 21, 2021 · Primary completion Dec 2027
Device: SpaceOAR Vue System · For: Prostate Cancer
Sites: Fort Myers, Florida; Tampa, Florida; Kansas City, Kansas · 30 sites in all
- SpaceIT Hydrogel System for Perirectal SpacingPivotal-lookingActive, not recruiting
Boston Scientific CorporationPublic (BSX)
NCT06451614 · 230 participants (planned) · Start Oct 30, 2024 · Primary completion Sep 30, 2026
Device: SpaceIT Hydrogel System; Commercially available Boston Scientific Spacer · For: Prostate Cancer
Sites: Laguna Hills, California; Los Angeles, California; Miami, Florida · 26 sites in all
Milton S. Hershey Medical CenterAcademic, hospital or other
NCT05650021 · 17 participants · Start Mar 8, 2024 · Primary completion Sep 15, 2025
Device: SpaceOAR Vue · For: Prostate Cancer
Sites: Hershey, Pennsylvania
2 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "SpaceOAR Vue", and for the whole product code for context.
This brand
1,137 reports: 807 malfunction, 324 injury, 6 death
Whole product code OVB
2,186 reports: 1,382 malfunction, 794 injury, 10 death
Newest reports for this brand
- SpaceOAR VUE? System - 10mLMalfunction
2124215-2026-57709 · Received Oct 29, 2026 · Event dated Oct 1, 2026
Device type: Hydrogel Spacer (OVB)
Device problem as coded: Malposition of Device
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- SpaceOAR VUE SystemInjury
2124215-2026-57416 · Received Oct 28, 2026 · Event dated Oct 5, 2026
Device type: Hydrogel Spacer (OVB)
Device problem as coded: Malposition of Device
Patient problem as coded: Diarrhea; Ulcer; Constipation
- SpaceOAR VUE SystemInjury
2124215-2026-57425 · Received Oct 28, 2026 · Event dated Jun 22, 2026
Device type: Hydrogel Spacer (OVB)
Device problem as coded: Malposition of Device; Migration
Patient problem as coded: Fever; Fistula; Hemorrhage/Blood Loss/Bleeding; Pain; Perforation; Ulcer; Dysuria
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1003-2022 · Started Feb 24, 2022
Reason given: Users need to be aware that embolism is a possible adverse event associated with hydrogel misplacements. Updated IFU provides new procedural instructions, warnings and precautions that describe steps to verify correct placement of the hydrogel following implantation, as well as technique recommendations for the proper...
Cause as FDA categorized it: Labeling design · Device type: Hydrogel Spacer (OVB)
Published research
The most relevant PubMed records for "SpaceOAR Vue"[tiab]. The summary above synthesizes these.
- Anaphylactic shock during SpaceOAR Vue hydrogel procedure.
Nesi L, Gogia P, Navalpakam A, et al. · Urol Case Rep · 2024Case Reports
- Radiological evaluation of an iodised hydrogel for prostate radiotherapy applications.
Kejda A, Bromley R, Bell L, et al. · Phys Med · 2023
- The case of the missing spacer!
Boerkamp A, De Robles MS · J Surg Case Rep · 2023Case Reports
- Application of Hydrogel Spacer SpaceOAR Vue for Prostate Radiotherapy.
Hadigal SR, Gupta AK · Tomography · 2022Review
- Utilization of Iodinated SpaceOAR Vueࡊ During Robotic Prostate Stereotactic Body Radiation Therapy (SBRT) to Identify the Rectal-Prostate Interface and Spare the Rectum: A Case Report.
Conroy D, Becht K, Forsthoefel M, et al. · Front Oncol · 2020Case Reports
- Case Report: Role of an Iodinated Rectal Hydrogel Spacer, SpaceOAR Vueࡊ, in the Context of Low-Dose-Rate Prostate Brachytherapy, for Enhanced Post-Operative Contouring to Aid in Accurate Implant Evaluation and Dosimetry.
Gross A, Yuan J, Spratt D, et al. · Front Oncol · 2021Case Reports
Other devices of this type
Also filed under product code OVB.
- SpaceOAR SystemAugmenix, Inc. · De Novo 2018
- SpaceOAR Flex SystemBoston Scientific Corporation · 510(k) 2026
- SpaceOAR Vue System (SV-2101)Boston Scientific Corporation · 510(k) 2026
- BioProtect Balloon Implant SystemBioprotect, Ltd. · 510(k) 2023
- Barrigel Injectable GelPalette Life Sciences · 510(k) 2022
- SpaceOAR SystemBoston Scientific Corporation · 510(k) 2020
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.